IMB Publications RSS Feed

Publications

Below you will find a list of all IMB Publications. You can filter this list by choosing from the tags on the left and you can select multiple tags if you wish. Before commencing a new search, please ensure you remove any tags/filters you have previously applied by clicking Remove Filters.

You can also search all Publications by entering a keyword(s) in the search box and clicking the Search link.

Search:  Search

Date	Title
19/02/2008	IMB Guide to Electronic Transmission of ICSRs and SUSARs Associated with Use of Human Medicines. Latest Information
23/04/2008	Abacavir & Didanosine-Important Safety Information from GlaxoSmithKline and Bristol-Myers Squibb as approved by the IMB
14/07/2008	Acomplia (rimonabant)-Important Safety Information from Sanofi Aventis as approved by the IMB
24/10/2008	Acomplia (rimonabant)-Important Safety Information from Sanofi Aventis concerning the suspension of Acomplia
08/12/2008	Acomplia (08 Dec)
20/08/2008	Adverse Reaction/Event Report Form Human Tissues and Cells
16/12/2008	Annual Report 2007
03/06/2008	Application for a Drug-Device Consultation
01/02/2008	Application for a Parallel Import Licence
01/08/2008	Application for a Registration Certificate for a Homeopathic Veterinary Medicinal Product
08/02/2008	Application for Addition of a Source Country to a Parallel Import Licence
01/02/2008	Application for Renewal of a Parallel Import Licence
30/09/2008	Arcoxia (etoricoxib)-Important Safety Information from Merck Sharp & Dohme following approval by the IMB
10/07/2008	Avastin (bevacizumab) & sunitinib malate-Important Safety Information from Roche as approved by the IMB
08/05/2008	Avastin (bevacizumab) - Important Safety Information from Roche as approved by the Irish Medicines Board
06/02/2008	Avelox (moxifloxacin)-Important Safety Information from Bayer HealthCare as approved by the IMB
08/04/2008	Batch-Specific Request Application Form
28/07/2008	Cabaser (cabergoline)-Important Safety Information from Pfizer as approved by the IMB
21/07/2008	Celance (pergolide)-Important Safety Information from Lilly as approved by the IMB
18/02/2008	CellCept (mycophenolate mofetil) - Important Safety Information from Roche on reports of PML in CellCept treated patients